Sign in

    Ron Kurtz

    President and Chief Executive Officer at Rxsight Inc
    Board
    Since 2016
    Age
    62 years
    Education
    Holds a B.A. in Biochemistry from Harvard College and an M.D. from the University of California, San Diego.
    Tenure
    Has served as President and Chief Executive Officer and board member of RxSight, Inc. since 2016.

    Also at Rxsight Inc

    EW
    Eric Weinberg
    Co-President and Chief Commercial Officer
    IG
    Ilya Goldshleger
    Co-President and Chief Operating Officer
    ST
    Shelley Thunen
    Co-President and Chief Financial Officer

    About

    Dr. Ron Kurtz has led RxSight, Inc. as President and Chief Executive Officer since 2016, concurrently serving as a board member and steering the company in the medical technology field.

    Before his tenure at RxSight, he co-founded LenSx Lasers, Inc., where he served as President and CEO, and later became General Manager at Alcon LenSx following its acquisition by Alcon Inc. He also co-founded IntraLase Corp., taking on the role of its initial President and CEO before the company transitioned into a publicly traded entity and was eventually acquired.

    Academically, he earned a B.A. in Biochemistry from Harvard College and an M.D. from the University of California, San Diego, and further contributed to academia through roles at the University of California, Irvine and the University of Michigan.

    $RXST Performance Under Ron Kurtz

    Past Roles

    OrganizationRoleDate RangeDetails
    LenSx Lasers, Inc. Co-founder, President and Chief Executive Officer; later General Manager of Alcon LenSx, Inc. following acquisition N/A Acquired by Alcon Inc. in 2010
    IntraLase Corp. (NASDAQ: ILSE) Co-founder, initial President and Chief Executive Officer; later held other senior leadership positions N/A Became publicly held in 2004 and was acquired by Advanced Medical Optics, Inc. (NYSE: AMO) in 2007
    University of California, Irvine Faculty Member N/A N/A
    University of Michigan Faculty Member N/A N/A

    Fixed Compensation

    Data from  FY 2024
    Component NameAmountPayment ScheduleAdditional Details
    Salary $678,333Regular payroll (annual)Base salary increased from $645,000 in 2023 to $685,000 effective March 1, 2024; 6.2% YOY increase
    Option Awards $5,537,883Grant Date: March 4, 2024149,000 stock options granted at an exercise price of $56.07 per share; fair value determined in accordance with FASB ASC 718
    All Other Compensation $6,504AnnualIncludes 401(k) matching contributions (up to 2% of eligible compensation) and an Inventor Bonus of $1,500

    Performance Compensation

    Data from  FY 2024

    Performance Compensation Components

    MetricWeightingThreshold / MinimumTargetMaximum/Cap
    Delighted Customers30%N/AN/AN/A
    - New Product Launch50% of segmentN/AN/AN/A
    - Submission Readiness25% of segmentN/AN/AN/A
    - International Regulatory Approvals25% of segmentN/AN/AN/A
    Motivated Employees30%N/AN/AN/A
    Shareholder Satisfaction40%N/AN/AN/A
    - LAL/LAL+ Sales40% of segmentN/AN/AN/A
    - Manufacturing Initiatives20% of segmentN/AN/AN/A
    - Financial Metrics (Revenue, Gross Margin, Cash Expenditures)40% of segmentRevenue: $125M, GM: 64%, Cash: $25MRevenue: $135M, GM: 67%, Cash: $18MRevenue: ≥$150M, GM: ≥68%, Cash: < $18M

    Payout & Vesting Details

    DetailValue
    Minimum Payout25% of target
    Target Payout100% of target
    Maximum Payout150% of target
    Actual Performance112% of corporate goals leading to a bonus payout at 112% of target
    Vesting Schedule (for Options)4-year vesting with 1/48th vesting monthly starting 1 month after the vesting commencement date
    Grant DateMarch 4, 2024
    Grant Date Fair Value$5,537,883
    Grant Date Stock Price$56.07
    Number of Stock Options149,000 shares
    Base Salary for Incentive Calculation$685,000 (used for bonus target)